Abstract
Low D-hormone syndrome, a disorder related to low creatinine clearance (CrCl), is associated with a roughly 4-fold increase in risk for falls. Known conditions leading to low D-hormone syndrome are CrCl < 65 ml/min, drug interactions, and chronic inflammatory diseases. This article reviews recent studies showing that treatment with D-hormone analogs, such as alfacalcidol, can reduce the frequency of falls in patients with low D-hormone syndrome.
MeSH terms
-
Accidental Falls / prevention & control*
-
Age Factors
-
Arthritis, Rheumatoid / complications*
-
Arthritis, Rheumatoid / drug therapy
-
Bone Density Conservation Agents / therapeutic use
-
Bone Diseases, Metabolic / blood
-
Bone Diseases, Metabolic / etiology*
-
Bone Diseases, Metabolic / metabolism
-
Calcitriol / blood
-
Calcitriol / deficiency*
-
Clinical Trials as Topic
-
Creatinine / metabolism*
-
Glucocorticoids / adverse effects*
-
Glucocorticoids / therapeutic use
-
Humans
-
Hydroxycholecalciferols / therapeutic use
-
Kidney / enzymology
-
Kidney / metabolism*
-
Risk Factors
-
Steroid Hydroxylases / metabolism
-
Syndrome
-
Vitamins / therapeutic use
Substances
-
Bone Density Conservation Agents
-
Glucocorticoids
-
Hydroxycholecalciferols
-
Vitamins
-
Creatinine
-
Steroid Hydroxylases
-
vitamin D 1-alpha hydroxylase
-
Calcitriol
-
alfacalcidol